Pharmaceutical News and Articles

Boehringer Receives U.S. FDA Breakthrough Therapy Designation and Initiates Two Phase III trials in MASH for Survodutide

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906),

Patients With Rheumatoid Arthritis Frequently Have Persisting Pain

Patients with rheumatoid arthritis (RA) undergoing standard-of-care treatment frequently have persisting pain, according to a study published online Sept. 30 in

FDA Approves Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

Hematologic Cancer Develops in Some Patients Receiving Eli-Cel

Hematologic cancer develops in some patients receiving lentiviral elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy, according to

1999 to 2018 Saw Decrease in Intake of Vitamin A, Vitamin C, Iron in Women

From 1999 to 2018, there was a decrease in vitamin A, vitamin C, and iron intake among pregnant and nonpregnant women, according to a study published online Oct

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Inc. (Nasdaq BIIB) Biogen announced today that felzartamab, an investigational anti-CD38 monoclonal antibody, has received Breakthrough Therapy Designati

Boys Treated With Gene Therapy for Rare Brain Disease Doing Well 6 Years Later

Most boys treated with breakthrough gene therapy for a rare but deadly brain illness are faring well six years later, two new reports find. The 77 boys were tre

Could Lingering Infection Be Causing Long COVID?

Some people might have Long COVID symptoms because the coronavirus is still active inside their bodies, a new study finds. People with wide-ranging Long COVID s

Hospitalizations Involving Alcohol Withdrawal Syndrome Common

In U.S. adults, hospitalizations involving alcohol withdrawal syndrome (AWS) are common, according to a study published online Oct. 8 in JAMA Network Open. Tess

Availability, Timeliness of Availability of New Cancer Drugs Vary

Across countries, there are considerable disparities in the availability and timeliness of availability of new cancer drugs, according to a study published onli